Check Pincode Serviceability
Bangalore, Metro cities: 1-3 business days, South India: 4-5 business days, North India: 5-7 business days, North east: 5-12 business days
Outside India: 5-10 business days
Indications of Schwabe Biocombination 22
Schwabe Biocombination No. 22 Scrofula Tablet is indicated for both dry and suppurating scrofulous abscesses. Almost all symptoms of the disease are covered.
Scrofulosis (Scrofula) is a morbid constitutional state of system characterized by indolent glandular tumors that suppurate slowly, heal with difficulty and leave scars. Well defined skin conditions of subcutaneous nodules which gradually enlarge, degenerate, ulcerate and terminate cutaneously. Scrofula as a typical, scar tissue is known as Scrofuloderma, lesions commonly occurring about the face, neck through lymph glands. These conditions are also covered by this medicine.
Calcarea phosphorica 3x, Ferrum phosphoricum 3x, Kalium muriaticum 3x, Silicea 6x in equal proportion.
Mode of action of individual ingredients in Schwabe Biocombination No 22
- Calcarea phosphorica: It is indicated for scrophulosis, chlorosis and phthisis covering tubercular glandular enlargements.
- Ferrum phosphoricum: It has been used in acute exacerbation of tuberculosis, inflammed throat, ulcerated sore throat and restlessness with fever.
- Kalium muriaticum: It is indicated for enlargement of tonsils, lymph glands, sore throat, follicular tonsillitis, vesicles and bursitis. Along with Calcarea phosphorica is covers disturbing symptoms of scrophulosis.
- Silicea: It is used for scrofulous children. It controls abscesses, organic changes and suppurative processes.
|Dosage||Adults 4 Tablets of Schwabe Biocombination No. 22 Scrofula, children 2 Tablets, at a time, four times a day at intervals of three hours.|
|Manufacturer||Dr.Willmar Schwabe india Pvt.Ltd|
|Form||Tablets of 100 mg in bottles of 20g and 550g.|